| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $154.0M | -23.2% |
| Cost of Revenue | $116.7M | -21.0% |
| Gross Profit | $37.3M | -29.4% |
| R&D Expense | $134.9M | -27.9% |
| SG&A Expense | $175.0M | +3.1% |
| Operating Income | -$474.3M | -41.8% |
| Pre-tax Income | -$309.5M | +2.7% |
| Income Tax | $316K | +102.8% |
| Net Income | -$309.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $55.4M | -69.2% |
| Short-term Investments | $334.6M | -25.9% |
| Accounts Receivable | $27.5M | -24.8% |
| Inventory | $58.8M | +3.7% |
| Current Assets | $495.7M | -33.2% |
| Total Assets | $1.26B | -27.8% |
| Current Liabilities | $66.3M | -30.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$206.1M | +20.5% |
| Capital Expenditures | $6.2M | -30.0% |
| Investing Cash Flow | $124.0M | +2593.4% |
| Financing Cash Flow | -$43.0M | -139.5% |
| Free Cash Flow | -$212.2M | +20.8% |
| -1.0% |
| EPS (Basic) | -$1.13 | +6.6% |
| EPS (Diluted) | -$1.59 | -31.4% |
| Total Liabilities |
| $753.9M |
| -27.8% |
| Stockholders' Equity | $506.6M | -27.8% |